IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Armstrong Teasdale
- Arnold & Porter
- Baker Botts
- Berger Montague
- Calcaterra Pollack
- Cicala Law Firm
- Cleary Gottlieb
- Cole Schotz
- Cotchett Pitre
- Cozen O'Connor
- Crowell & Moring
- Cuneo Gilbert
- DeCotiis FitzPatrick
- DiCello Levitt
- DLA Piper
- Dugan Law Firm
- Faegre Drinker
- Fine Kaplan
- Foley & Lardner
- Fox Rothschild
- Freedman Boyd
- Girard Sharp
- Grant & Eisenhofer
- Hagens Berman
- Hausfeld LLP
- Hogan Lovells
- Joseph Saveri Law Firm
- Kaplan Fox
- Kasowitz Benson
- Kirkland & Ellis
- Larson King
- Law Offices of Francis O. Scarpulla
- Lieff Cabraser
- Linklaters LLP
- Lite DePalma
- Lockridge Grindal
- Lowey Dannenberg
- Marks O'Neill
- Miller & Chevalier
- Miller Shah LLP
- Morgan Lewis
- Morrison Foerster
- Motley Rice
- Napoli Shkolnik
- NastLaw
- Neal & Harwell
- Norton Rose
- Nussbaum Law Group
- Petrillo Klein
- Pogust Goodhead
- Reed Smith
- Schertler Onorato
- Schneider Wallace
- Simpson Thacher & Bartlett LLP
- Spiro Harrison
- Steptoe LLP
- Steven Williams Law
- Stueve Siegel
- Tostrud Law Group
- Troutman Pepper
- Weil Gotshal
- Welsh & Recker
- White and Williams
- Williams & Connolly
- Wilson Sonsini
Companies
- Bausch Health Cos. Inc.
- Cardinal Health Inc.
- Health Care Service Corp.
- LifeWallet
- Molina Healthcare Inc.
- Red Oak Sourcing LLC
- The Harvard Drug Group LLC
- Walgreens Boots Alliance Inc.
Government Agencies
Sectors & Industries:
-
November 09, 2022
Drug Buyers, States Want To Depose Indicted Ex-Taro Exec
A group of drug purchasers and state-level enforcers accusing generic-drug manufacturers of fixing prices asked a Pennsylvania federal court on Tuesday to allow it to depose a former top executive who was indicted on criminal antitrust charges ahead of his trial.
-
June 07, 2022
AGs' Disgorgement Claim Axed In Drug Price-Fixing Case
The Pennsylvania federal judge overseeing sprawling price-fixing litigation against generic-drug makers on Tuesday tossed a disgorgement claim brought by state attorneys general, but kept alive their claim for injunctive relief.
-
May 25, 2022
Generic Distributors Slip Indirect Reseller Price-Fixing Claims
A Pennsylvania federal judge dismissed, for now, indirect generic-drug resellers' price-fixing claims levied against distributors like McKesson Corp. as a part of multidistrict litigation, ruling Wednesday that the plaintiffs failed to sufficiently allege a conspiracy.
-
May 20, 2022
Drugmakers Say Pa. AG Not Producing Generic-Drug Docs
Mylan and other pharmaceutical companies facing allegations of price-fixing for generic drugs told a Pennsylvania federal judge overseeing multidistrict litigation that the Pennsylvania Attorney General's Office has refused to produce key documents.
-
May 11, 2022
Settlements Worth $86M OK'd In Drug Price-Fixing MDL
Deals for three generic-drug companies to fork over a combined $86 million to direct purchasers and indirect resellers to settle price-fixing allegations gained preliminary approval from a Philadelphia federal judge Wednesday.
-
May 10, 2022
End-Payor State Claims Stick In Generic Drug Price-Fix MDL
A Pennsylvania federal court denied a dismissal bid Tuesday from drug companies in sprawling multidistrict litigation over alleged generic drug price-fixing, refusing to toss some state claims from end-payors while rejecting arguments that intervening authority should result in the claims being nixed.
-
April 07, 2022
Teva Appears Headed For $100M Price-Fixing Payout To AGs
After last week's $1.45 million settlement with Louisiana's attorney general, a pattern is emerging in Teva's efforts to deal its way out of sprawling price-fixing litigation that could put the generic-drug maker on the hook for about $100 million if it settles with every state enforcer.
-
March 16, 2022
Drug Purchasers Seek Blessing Of Sun And Taro Deals
Generic-drug buyers on Wednesday asked a Pennsylvania federal court to certify a settlement class and preliminarily approve settlements with Sun Pharma and Taro Pharmaceuticals worth a combined $85 million, the first on behalf of any private plaintiff in sprawling multidistrict litigation over alleged price-fixing of generic drugs.
-
March 09, 2022
Nothing 'Innocuous' In Drugmakers' Dismissal Bid, Court Told
Generic-drug buyers urged a Pennsylvania federal judge Tuesday not to consider a dismissal bid from pharmaceutical companies more recently added to multidistrict price-fixing litigation, arguing the motion was filed in violation of an agreement to tackle bellwether cases first.
-
November 05, 2021
2 Sun Pharma US Units To Pay $85M In Generic Drugs MDL
Two U.S. subsidiaries of Indian drugmaker Sun Pharma have agreed to shell out a combined $85 million to a proposed class of direct purchaser plaintiffs in sweeping multidistrict litigation over alleged price-fixing of generic drugs, the companies have reportedly disclosed.